Clinical Trials Update from the Heart Failure Society of America and the American Heart Association Meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, Thyroid Hormone analogue Study, HF-ACTION, I-PRESERVE, β-Interferon Study, BACH, and ATHENA
Open Access
- 28 January 2009
- journal article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 11 (2) , 214-219
Abstract
This article provides information and a commentary on trials relevant to the pathophysiology, prevention, and treatment of heart failure presented at the Heart Failure Society of America and the American Heart Association meetings in 2008. Unpublished reports should be considered as preliminary, as analyses may change in the final publication. (i) SADHART‐CHF showed no difference in outcome for heart failure patients with depression treated with sertraline compared with placebo. (ii) A controlled release carvedilol formulation showed similar LV haemodynamic effects to the standard carvedilol formulation in the COMPARE study. (iii) A post hoc analysis of the MOMENTUM study suggested that patients with less severe heart failure may be more likely to benefit from a continuous aortic flow augmentation device. (iv) A thyroid hormone analogue was poorly tolerated in patients with heart failure. (v) HF‐ACTION showed that exercise training is safe and offers modest clinical benefits in patients with heart failure. (vi) Irbesartan failed to improve outcomes in patients with preserved ejection fraction in the I‐PRESERVE study. (vii) A phase II study of beta‐interferon administration in patients with dilated cardiomyopathy showed encouraging results. (viii) The BACH study showed that mid‐regional pro‐adrenomedullin was more accurate than BNP or NT‐proBNP at predicting outcome at 90 days in patients with acute heart failure. (ix) A secondary analysis from ATHENA showed a reduction in cardiovascular hospitalizations and strokes for patients with atrial fibrillation receiving dronedarone compared with placebo.Keywords
This publication has 27 references indexed in Scilit:
- Cardiac Resynchronization TherapyJACC, 2009
- Effects of Continuous Aortic Flow Augmentation in Patients With Exacerbation of Heart Failure Inadequately Responsive to Medical TherapyCirculation, 2008
- Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failureAmerican Heart Journal, 2008
- Effect of dronedarone on renal function in healthy subjectsBritish Journal of Clinical Pharmacology, 2007
- Relationship between depressive symptoms and long-term mortality in patients with heart failureAmerican Heart Journal, 2007
- Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION): Design and rationaleAmerican Heart Journal, 2007
- Depression in Heart FailureJACC, 2006
- COMPARE: Comparison of the Effects of Carvedilol CR and Carvedilol IR on Left Ventricular Ejection Fraction in Patients with Heart FailureThe American Journal of Cardiology, 2006
- Clinical and Experimental Studies on the Use of 3,5-Diiodothyropropionic Acid, a Thyroid Hormone Analogue, in Heart FailureThyroid®, 2002
- Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1994